Phase 2a, randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study of a H4R‐antagonist (JNJ‐39758979) in Japanese adults with moderate atopic dermatitis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 2, 2015-02 ,pp. : 129-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized, Double Blind, Placebo Controlled, Crossover Study to Assess the Safety and Beneficial Effects of Cassia Tora Supplementation in Healthy Adults

By  

Reviews on Recent Clinical Trials, Vol. 13, Iss. 1, 2018-01 ,pp. : 69-78

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of sitagliptin on counter‐regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double‐blind placebo‐controlled crossover study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 546-553

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Efficacy and Safety of a Chinese Herbal Product (Xiao-Feng-San) for the Treatment of Refractory Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

International Archives of Allergy and Immunology, Vol. 155, Iss. 2, 2010-12 ,pp. : 141-148

Karger

Access to resources Recommend Favorite

Changes in Blood Leukocyte Distribution during Double-Blind, Placebo-Controlled Food Challenges in Children with Atopic Dermatitis and Suspected Food Allergy

By  

International Archives of Allergy and Immunology, Vol. 116, Iss. 2, 1998-06 ,pp. : 110-115

Karger

Access to resources Recommend Favorite